Contrary to its conventional role in some tumors, p21 are correlated with poor prognosis, increased metastasis and high tumor grade in subsets of tumors, such as breast cancer, prostate cancer, cervical carcinomas, lymphomas as well as head and neck cancer [42, 43]. Here, CDKN1A is linked to prostate carcinoma.